UNITED GREENERIES
Dead / Abandoned — Abandoned — failure to respond (as of 07 Jan 2021)
What this means for you
This application is over — abandoned 29 Dec 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86532961
- Mark type
- Stylized text
- Filed
- 12 Feb 2015
- Abandoned
- 29 Dec 2020
- Attorney of record
- Kimberly N. Fisher
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Cannabis compounds not for medicinal purposes comprised of legal cannabis products; unmedicated cannabis preparations and derivative products in the form of personal care preparations for the body, namely, creams, oils, emollients, ointments, rubs, lotions, and salves, comprised of legal cannabis products; unmedicated products, plants, dried plant material, seeds and medicines derived from and related to the cannabis plant, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors antioxidants, antidepressants and antihypertensives comprised of legal cannabis products
- Class 005 — Pharmaceuticals: Cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicated cannabis preparations in the form of personal care preparations for the body, namely, creams, oils, emollients, ointments, rubs, lotions, and salves comprising legal cannabis products; synthetic narcotics for medical use; pharmaceutical preparations for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceutical preparations containing one or more legal cannabinoids as the active ingredient for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicines containing a legal tetrahydrocannabinol extract for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicines derived from legal cannabis for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; nutraceuticals and medicines comprising legal cannabis products derived from and related to the cannabis plant for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicated products, plants, dried plant material, seeds and medicines derived from and related to the cannabis plant, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors antioxidants, antidepressants and antihypertensives comprised of legal cannabis products
- Class 009 — Scientific and electric apparatus: Magnetically encoded cards for medical purposes, namely, membership and identification cards; magnetically encoded cards for use in connection with customer loyalty, rewards, bonus points, and discount programs
- Class 035 — Advertising and business services: Medical dispensary featuring cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products; online operation of a medical dispensary featuring cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products; operation of a retail store featuring cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products; retail and wholesale store reward programs, namely, arranging and conducting incentive reward programs to promote the sale of cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products; promoting the goods and services of others by means of the issuance of loyalty rewards cards, namely, providing identification cards for use in connection with customer loyalty, rewards, bonus points, and discount programs
- Class 042 — Scientific and technological services: Medical research services; medical research services in the field of cannabis and medical marihuana; product development services
- Class 044 — Medical, beauty and agricultural services: Operation of a computer database featuring medical information in the field of medical marihuana; operation of a website containing medical information in the field of marihuana and cannabis
- Class 045 — Legal and security services: Operation of a web site that provides online social networking
Owner
- UNITED GREENERIES HOLDINGS LTD., VANCOUVER, CA
- MMJ Bioscience Inc, Vancouver, CA
Prosecution history
- 07 Jan 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 07 Jan 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 26 Jun 2020 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 26 Jun 2020 — FINAL REFUSAL E-MAILED
- 26 Jun 2020 — FINAL REFUSAL WRITTEN
- 11 Jun 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jun 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Jun 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Jan 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Jan 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Dec 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Dec 2019 — NON-FINAL ACTION E-MAILED
- 11 Dec 2019 — NON-FINAL ACTION WRITTEN
- 30 Sept 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Sept 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE